The product name is not the issue. In #msg-30283097 you said:
“i know we have discussed this prior, but what was the major holdup w/ Genzyme Transgenics and use of "Atryn" for HD in earlier P3 trial?”
To which I replied that ATryn was not tested in the HD indication during the “Genzyme Transgenics” days. The phase-3 trial trial you cited in #msg-30280763 was in CABG/HR, not in HD.
Market Data 
Markets 
AI
